GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Innospec Inc (NAS:IOSP) » Definitions » EBITDA
中文

Innospec (Innospec) EBITDA

: $204 Mil (TTM As of Dec. 2023)
View and export this data going back to 1998. Start your Free Trial

Innospec's EBITDA for the three months ended in Dec. 2023 was $55 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $204 Mil.

During the past 12 months, the average EBITDA Growth Rate of Innospec was -11.70% per year. During the past 3 years, the average EBITDA Growth Rate was 31.90% per year. During the past 5 years, the average EBITDA Growth Rate was 4.00% per year. During the past 10 years, the average EBITDA Growth Rate was 3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Innospec was 35.30% per year. The lowest was -37.80% per year. And the median was 3.90% per year.

Innospec's EBITDA per Share for the three months ended in Dec. 2023 was $2.18. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2023 was $8.14.

During the past 12 months, the average EBITDA per Share Growth Rate of Innospec was -11.80% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 31.50% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 3.60% per year. During the past 10 years, the average EBITDA per Share Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Innospec was 37.00% per year. The lowest was -38.70% per year. And the median was 4.90% per year.


Innospec EBITDA Historical Data

The historical data trend for Innospec's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innospec Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 202.80 87.50 173.00 227.40 200.90

Innospec Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.80 50.30 46.80 51.80 54.70

Competitive Comparison

For the Specialty Chemicals subindustry, Innospec's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innospec EV-to-EBITDA Distribution

For the Chemicals industry and Basic Materials sector, Innospec's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Innospec's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Innospec's EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Innospec's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2023, Innospec's EBITDA was $201 Mil.

Innospec's EBITDA for the quarter that ended in Dec. 2023 is calculated as

Innospec's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2023, Innospec's EBITDA was $55 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $204 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Innospec  (NAS:IOSP) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Innospec EBITDA Related Terms

Thank you for viewing the detailed overview of Innospec's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Innospec (Innospec) Business Description

Traded in Other Exchanges
Address
8310 South Valley Highway, Suite 350, Englewood, CO, USA, 80112
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The fuel specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field services providers in the extraction of oil and gas. The performance chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.
Executives
Larry Padfield director 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
Claudia Poccia director 8310 SOUTH VALLEY HIGHWAY, SUITE 350, ENGLEWOOD CO 80112
Leslie J Parrette director
Barnes Corbin officer: SVP, Corporate Dev and IR 8310 SOUTH VALLEY HIGHWAY, SUITE 350, ENGLEWOOD CO 80112
Philip John Boon other: Marketing Director Pet Specs 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
Ian Cleminson officer: Exec VP & CFO OAK DALE, 84 ALBERT ROAD, GRAPPENHALL, WARRINGTON X0 WA4 2PG
Patrick Williams officer: Exec VP & President, Pet Specs 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
Bentley Jones David officer: VP, GC & CCO 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
David Landless director 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
Milton C Blackmore director 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
Brian Watt other: VP, Strategic Planning THE LODGE, HUSTHWAITE, YORK X0 YO61 4PD
Catherine Hessner officer: Senior VP - Human Resources 33 STRAWBERRY LANE, WILMSLOW CHESHIRE X0 SK96AQ
Griffin Hardy Louis Iii officer: SVP, HUMAN RESOURCES 8310 SOUTH VALLEY HIGHWAY, SUITE 350, ENGLEWOOD CO 80112
Elizabeth K Arnold director 8310 S. VALLEY HWY, SUITE 350, DENVER CO 80112
Graeme Blair officer: Head of Group Finance 8310 SOUTH VALLEY HIGHWAY, SUITE 350, ENGLEWOOD CO 80112

Innospec (Innospec) Headlines